NCT02068144View on ClinicalTrials.gov

The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 2, 2016

Study Completion Date

July 11, 2018

Conditions
Insulin ResistanceAtherosclerosis
Interventions
DIETARY_SUPPLEMENT

Cranberry Extract

Participants will drink one 15.2 oz bottle of Cranberry Extract beverage daily for 8 weeks.

OTHER

Placebo

Participants will drink one 15.2oz bottle of placebo beverage daily for 8 weeks.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
collaborator

Ocean Spray, Inc.

INDUSTRY

lead

Pennington Biomedical Research Center

OTHER

NCT02068144 - The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans | Biotech Hunter | Biotech Hunter